Komori
KENKO Mayonnaise (2915) · InitiativeDecline in product development personnel and R&D expenses

Development of Safe, Health-Oriented and Higher-Value-Added Products

First written in FY2016. 15 of 29 entries say "Restated". Latest entry: FY2026.

29entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019-Q1 – FY2020-Q3RestatedFY2021-Q2 – FY2023-Q2OtherFY2024-Q2 – FY20262016: 320162017: 420172018: 220182019: 420192020: 320202021: 320212022: 420222023: 220232024: 220242025: 120252026: 12026
Same theme, other companies

The whole theme swung hardest in 2022: 1 of 7 companies on the "Worse" side.

0 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026Decline in product development personnel and R&D expensesAnnual report

    「In the Group’s seasonings and processed foods business, approximately 40 development staff conduct research on raw materials and ingredients, develop products by category, including mayonnaise and dressings, salads and prepared foods, and processed egg products, and develop menu items using the Company’s products.」

    The Company continued category-based product development and menu development, but the development staff decreased to approximately 40 and R&D expenses amounted to ¥324 million. The development structure and spending scale contracted from approximately 80 staff and ¥435 million in the previous fiscal year.
  2. FY2026-H1Decline in R&D expenditure for the interim periodAnnual report

    「The amount of R&D expenses incurred by the Group during the interim consolidated accounting period was ¥166 million.」

    R&D expenses for the interim period were ¥166 million, down from ¥212 million in the same period of the previous year. The R&D activities themselves are continuing.
  3. FY2024Modest increase in R&D expensesAnnual report

    「In the Group’s seasonings and processed foods business, approximately 80 development staff conduct research on raw materials and ingredients, develop products by category, including mayonnaise and dressings, salads and prepared foods, and processed egg products, and develop menu items using the Company’s products. R&D expenses related to the seasonings and processed foods business for the fiscal year were ¥435 million.」

    The Company continued its development structure of approximately 80 staff, along with category-based product development and menu development, and R&D expenses increased from ¥429 million in the previous fiscal year to ¥435 million.
  4. FY2024-Q3Increase in quarterly R&D expenseAnnual report

    「The amount of R&D expenses incurred by the Group during the third quarter of the current consolidated cumulative period was ¥327 million.」

    R&D expenses for the nine-month period were ¥327 million, up from the cumulative ¥212 million reported for FY2024-Q2. R&D activities are continuing.
  5. FY2024-Q2RestatedAnnual report

    「The amount of R&D expenses incurred by the Group during the second quarter of the current consolidated cumulative period was ¥212 million.」

    The Company continued its R&D activities and disclosed R&D expenses of ¥212 million for the six-month period.
  6. FY2023AdvancedAnnual report

    「In the Group’s seasonings and processed foods business, approximately 80 development staff conduct research on raw materials and ingredients, develop products by category, including mayonnaise and dressings, salads and prepared foods, and processed egg products, and develop menu items using the Company’s products. R&D expenses related to the seasonings and processed foods business for the fiscal year were ¥429 million.」

    The Company continued category-based product development and menu development with approximately 80 development staff, and R&D expenses increased from ¥380 million in the previous fiscal year to ¥429 million.
  7. FY2023-Q2Increase in R&D ExpensesAnnual report

    「The amount of R&D expenses incurred by the Group during the second quarter of the current consolidated cumulative period was ¥213 million.」

    R&D expenses for the first six months were ¥213 million, up from ¥141 million in the same period of the previous year.
  8. FY2023-Q1Increase in quarterly R&D expenseAnnual report

    「The amount of R&D expenses incurred by the Group during the first quarter of the current consolidated cumulative period was ¥117 million.」

    The Company continued its R&D activities, with R&D expenses reaching ¥117 million, up from ¥74 million in the same period of the previous year.
  9. FY2022Decline in product development personnel and R&D expensesAnnual report

    「In the Group’s seasonings and processed foods business, approximately 70 development staff conduct research on raw materials and ingredients, develop products by category, including mayonnaise and dressings, salads and prepared foods, and processed egg products, and develop menu items using the Company’s products. R&D expenses related to the seasonings and processed foods business for the fiscal year were ¥380 million.」

    The Company continued product development by category and menu development, with approximately 70 development staff and R&D expenses of ¥380 million, down from ¥614 million in the previous fiscal year.
  10. FY2022-Q3RestatedAnnual report

    「The R&D expenses incurred by the Group during the cumulative third quarter of the current consolidated fiscal year were ¥332 million.」

    The Company disclosed R&D expenses of ¥332 million for the cumulative third quarter and reconfirmed the continuation of its R&D activities.
  11. FY2022-Q2RestatedAnnual report

    「The R&D expenses incurred by the Group during the cumulative second quarter of the current consolidated fiscal year were ¥141 million.」

    The Company disclosed R&D expenses of ¥141 million for the cumulative second quarter and reconfirmed the continuation of its R&D activities.
  12. FY2022-Q1RestatedAnnual report

    「The R&D expenses incurred by the Group during the cumulative first quarter of the current consolidated fiscal year were ¥74 million.」

    The Company disclosed R&D expenses of ¥74 million for the cumulative first quarter and reconfirmed the continuation of its R&D activities.
  13. FY2021-Q3RestatedAnnual report

    「The total R&D expenses incurred by the Group during the cumulative third quarter of the current consolidated fiscal year were ¥467 million.」

    The Company disclosed R&D expenses of ¥467 million for the cumulative third quarter and reconfirmed the continuation of its R&D activities.
  14. FY2021-Q2RestatedAnnual report

    「The R&D expenses incurred by the Group during the cumulative second quarter of the current consolidated fiscal year were ¥314 million.」

    The Company continued its R&D activities and disclosed R&D expenses of ¥314 million for the cumulative second quarter.
  15. FY2020AdvancedAnnual report

    「In the Group's Seasonings and Processed Foods Business, approximately 80 product development personnel are engaged in category-specific product development, including mayonnaise and dressings, prepared and processed foods, and processed egg products, as well as menu development using the Company's products. R&D expenses for the Seasonings and Processed Foods Business during the consolidated fiscal year were ¥614 million.」

    The category-specific and menu development organization supported by approximately 80 product development personnel was maintained, and annual R&D expenses were ¥614 million.
  16. FY2020-Q3RestatedAnnual report

    「The total R&D expenses incurred by the Group during the cumulative third quarter of the current consolidated fiscal year were ¥471 million.」

    The Company disclosed R&D expenses of ¥471 million for the cumulative third quarter and continued its R&D activities.
  17. FY2020-Q2RestatedAnnual report

    「The total R&D expenses incurred by the Group during the cumulative second quarter of the current consolidated fiscal year were ¥316 million.」

    The Company continued its R&D activities and disclosed R&D expenses of ¥316 million for the cumulative second quarter.
  18. FY2020-Q1RestatedAnnual report

    「The R&D expenses incurred by the Group during the cumulative first quarter of the current consolidated fiscal year were ¥163 million.」

    The Company disclosed R&D expenses of ¥163 million for the cumulative first quarter and continued its R&D activities.
  19. FY2019RestatedAnnual report

    「The Seasonings and Processed Foods Business has approximately 80 product development personnel. The core teams are product development teams for each category, including mayonnaise and dressings, prepared and processed foods, and processed egg products, together with a team that develops menus using the Company's products.」

    The R&D organization comprising approximately 80 product development personnel and category-specific and menu development teams has been maintained.
  20. FY2019-Q3RestatedAnnual report

    「The total R&D expenses incurred by the Group during the cumulative third quarter of the current consolidated fiscal year were ¥444 million.」

    The Company continued its R&D activities and disclosed R&D expenses of ¥444 million for the cumulative third quarter.
  21. FY2019-Q1RestatedAnnual report

    「The R&D expenses incurred by the Group during the cumulative first quarter of the current consolidated fiscal year were ¥153 million.」

    The Company continued to disclose its R&D activities and R&D expenses of ¥153 million for the cumulative first quarter.
  22. FY2018AdvancedAnnual report

    「The Seasonings and Processed Foods Business has approximately 80 product development personnel. The core teams are product development teams for each category, including mayonnaise and dressings, prepared and processed foods, and processed egg products, together with a team that develops menus using the Company's products.」

    Product development personnel increased from approximately 70 to approximately 80, and R&D expenses of ¥545 million were recorded. The Company also launched the new Kenko Refine product, made with domestically produced vegetables and other ingredients.
  23. FY2018-Q2AdvancedAnnual report

    「In response to growing health consciousness, the Frozen Seven-Grain Mix, made with quinoa and other ingredients attracting attention as superfoods, received the Gold Award in the commercial food category at the 1st Japan Grains Award, operated by the Japan雑穀 Association.」

    A health-oriented product made with quinoa and other ingredients received the Gold Award at the Japan Grains Award, providing a result from the development of high-value-added, health-oriented products.
  24. FY2018-Q1AdvancedAnnual report

    「Two products in the Magokoro Shokusai® brand series, developed for senior-care facilities and hospital food services, received the Director-General's Award of the Food Industry Affairs Bureau of the Ministry of Agriculture, Forestry and Fisheries and the Chairperson of the Judging Committee's Award at the 3rd Care Food (Smile Care Food) Contest, organized by The Japan Food Journal and supported by the Ministry of Agriculture, Forestry and Fisheries.」

    Two products for senior-care facilities and hospital food services won awards at a care-food contest, providing a specific result from the development of healthy, high-value-added products.
  25. FY2017AdvancedAnnual report

    「The Seasonings and Processed Foods Business has approximately 70 product development personnel. The core teams are product development teams for each category, including mayonnaise and dressings, prepared and processed foods, and processed egg products, together with a team that develops menus using the Company's products.」

    The product development organization has grown to approximately 70 personnel and comprises category-specific development teams and a menu development team. Full-year R&D expenses were ¥536 million.
  26. FY2017-Q3RestatedAnnual report

    「The total R&D expenses incurred by the Group during the cumulative third quarter of the current consolidated fiscal year were ¥412 million.」

    The Company continued its R&D activities and disclosed R&D expenses of ¥412 million for the cumulative third quarter, but announced no new development milestone.
  27. FY2017-Q2RestatedAnnual report

    「The total R&D expenses incurred by the Group during the cumulative second quarter of the current consolidated fiscal year were ¥275 million.」

    The Company continued its R&D activities and disclosed R&D expenses of ¥275 million for the cumulative second quarter of the current consolidated fiscal year.
  28. FY2017-Q1RestatedAnnual report

    「The total R&D expenses incurred by the Group during the cumulative first quarter of the current consolidated fiscal year were ¥140 million.」

    The Company disclosed continued R&D activities and R&D expenses of ¥140 million for the cumulative period of the current quarter.
  29. FY2016First statedAnnual report

    「The Seasonings and Processed Foods Business has approximately 60 product development personnel. The core teams are product development teams for each category, including mayonnaise and dressings, prepared and processed foods, and processed egg products, together with a team that develops menus using the Company's products.」

    The Company is advancing the development of safe and reassuring, health-oriented and high-value-added products, supported by approximately 60 product development personnel and category-specific teams.
Moved together

"Establishing the No. 1 Position in Salads" moved the same way as this thread, in the same document, in 6 of its 29 moves.

655543★123456
  1. ★This thread
  2. 1Establishing the No. 1 Position in Salads6×
  3. 2Addressing increasingly diverse and sophisticated customer needs5×
  4. 3Expansion into a Manufacturer Capable of Handling the Full Range of Prepared Foods5×
  5. 4Balancing Proactive Investment for Growth with Financial Soundness5×
  6. 5Expanding Production Capacity through Plant Investment4×
  7. 6Improving net sales, ordinary profit margin and equity ratio3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for KENKO Mayonnaise yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Development of Safe, Health-Oriented and Higher-Value-Added Products | KENKO Mayonnaise Co.,Ltd. (2915) | Komori